A new class of drugs has become a phenomenon. GLP-1 receptor agonists, originally developed to treat type 2 diabetes, are now ...

SHOPPING: Shedding unwanted pounds no longer has to be a challenge thanks to this affordable alternative to Ozempic that's ...

Ozempic and drugs like it have done wonders for weight loss by mimicking the natural hormone GLP-1 (glucagon-like peptide-1), ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

There is zero evidence that ​​semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...

I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple ...

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

Ozempic, a drug originally developed for diabetes but now widely used for weight loss, has been praised for helping many people shed extra pounds. However, questions have been raised about whether the ...

Ozempic has, in the recent times, become popular for weight loss, but new research hints it may hamper muscle strength, even ...

Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.